[1] E. Moscarella et al., “Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease,” Cardiology Clinics, vol. 38, no. 4, pp. 575–588, Nov. 2021, doi: 10.1016/j.ccl.2020.07.003.
[2] J. Nogic et al., “The assessment of intermediate coronary lesions using intracoronary imaging,” Cardiovascular Diagnosis and Therapy, vol. 10, no. 5, pp. 1445–1460, Oct. 2020, doi: 10.21037/cdt-20-226.
[3] D. Zhang et al., “Fractional flow reserve versus angiography for guiding percutaneous coronary intervention: a meta-analysis,” Heart, vol. 101, no. 6, pp. 455–462, Mar. 2015, doi: 10.1136/heartjnl-2014-306578.
[4] J. S. Lawton et al., “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization,” Journal of the American College of Cardiology, vol. 79, no. 2, pp. 21–129, Jan. 1AD, doi: 10.1016/j.jacc.2021.09.006.
[5] S. Tu et al., “Fractional Flow Reserve Calculation From 3-Dimensional Quantitative Coronary Angiography and TIMI Frame Count,” JACC: Cardiovascular Interventions, vol. 7, no. 7, pp. 768–777, Jul. 2014, doi: 10.1016/j.jcin.2014.03.004.
[6] J. Westra et al., “Diagnostic performance of quantitative flow ratio in prospectively enrolled patients: An individual patient-data meta-analysis,” Catheterization and Cardiovascular Interventions, vol. 94, no. 5, pp. 693–701, Nov. 2019, doi: 10.1002/ccd.28283.
[7] M. Finizio et al., “Comparison of Quantitative Flow Ratio and Invasive Physiology Indices in a Diverse Population at a Tertiary United States Hospital,” Cardiovascular Revascularization Medicine, vol. 32, pp. 1–4, Nov. 2021, doi: 10.1016/j.carrev.2021.06.115.
[8] Z. Xing, J. Pei, J. Huang, X. Hu, and S. Gao, “Diagnostic Performance of QFR for the Evaluation of Intermediate Coronary Artery Stenosis Confirmed by Fractional Flow Reserve,” Brazilian Journal of Cardiovascular Surgery, vol. 34, no. 2, pp. 165–172, Apr. 2019, doi: 10.21470/1678-9741-2018-0234.
[9] B. Xu et al., “Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial,” The Lancet, vol. 398, no. 10317, pp. 2149–2159, Dec. 2021, doi: 10.1016/S0140-6736(21)02248-0.
[10] W. Zuo, M. Yang, Y. Chen, A. Xie, L. Chen, and G. Ma, “Meta-Analysis of Diagnostic Performance of Instantaneous Wave-Free Ratio versus Quantitative Flow Ratio for Detecting the Functional Significance of Coronary Stenosis,” BioMed Research International, vol. 2019, no. 5828931, Apr. 2019, doi: 10.1155/2019/5828931.
[11] C. Cortés et al., “Quantitative flow ratio-Meta-analysis and systematic review,” Catheterization and Cardiovascular Interventions, vol. 97, no. 5, pp. 807–814, Mar. 2020, doi: 10.1002/ccd.28857.
[12] M. E. Edep, E. M. Guarneri, P. S. Teirstein, P. S. Phillips, and D. L. Brown, “Differences in TIMI frame count following successful reperfusion with stenting or percutaneous transluminal coronary angioplasty for Acute Myocardial Infarction,” The American Journal of Cardiology, vol. 83, no. 9, pp. 1326–1329, May 1999, doi: 10.1016/S0002-9149(99)00094-6.
[13] C. M. Gibson et al., “TIMI frame count: a quantitative method of assessing coronary artery flow,” Circulation, vol. 93, no. 5, pp. 879–888, Mar. 1996, doi: 10.1161/01.cir.93.5.879.
[14] V. Kunadian et al., “Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years,” Journal of Thrombosis and Thrombolysis volume, vol. 27, p. 316, Apr. 2008, doi: 10.1007/s11239-008-0220-3.
[15] A. Manginas, P. Gatzov, C. Chasikidis, V. Voudris, G. Pavlides, and D. Cokkinos, “Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method,” The American Journal of Cardiology, vol. 83, no. 11, pp. 1562–5, Jun. 1999, doi: 10.1016/s0002-9149(99)00149-6.
[16] B. A. Faile, J. A. Guzzo, D. A. Tate, T. C. Nichols, S. C. Smith, and G. J. Dehmer, “Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow,” American Heart Journal, vol. 140, no. 2, pp. 308–314, Aug. 2000, doi: 10.1067/mhj.2000.108003.
[17] A. Abaci, A. Oguzhan, N. K. Eryol, and A. Ergin, “Effect of potential confounding factors on the Thrombolysis in Myocardial Infarction (TIMI) trial frame count and its reproducibility,” Circulation, vol. 100, no. 22, pp. 2219–2223, Nov. 1999, doi: 10.1161/01.cir.100.22.2219.
[18] J. French et al., “Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity,” American Journal of Cardiology, vol. 81, no. 6, pp. 665–671, Mar. 1998, doi: 10.1016/s0002-9149(97)01004-7.
[19] G. Stankovic et al., “Prediction of restenosis after coronary angioplasty by use of a new index: TIMI frame count/minimal luminal diameter ratio,” Circulation, vol. 101, no. 9, pp. 962–8, Mar. 2000, doi: 10.1161/01.cir.101.9.962.
[20] M. A. Appleby, A. D. Michaels, M. Chen, and C. M. Gibson, “Importance of the TIMI frame count: implications for future trials,” Current Controlled Trials in Cardiovascular Medicine, vol. 1, no. 1, pp. 31–34, Feb. 2000, doi: 10.1186/cvm-1-1-031.
[21] G. A. ten Brinke, C. H. Slump, and M. G. Stoel, “Automated TIMI frame counting using 3-d modeling,” Computerized Medical Imaging and Graphics, vol. 36, no. 7, pp. 580–588, Oct. 2012, doi: 10.1016/j.compmedimag.2012.07.001.